INFLECTION MEDICINE

Class 35: New product commercialization of diagnostic products for genetic diseases and disorders; new product commercialization services of technology to improve clinical outcomes of individuals with genetic diseases and disorders; new product commercialization services of diagnostic products for identifying genetic diseases and disorders; new product commercialization services of technology that provides clinical guidance

diagnostic tests consisting primarily of buffers and reagents for detecting genetic diseases and disorders

Development of diagnostic apparatus and testing kits for genetic diseases and disorders; development of technology to improve clinical outcomes of individuals with genetic diseases and disorders; development of diagnostic apparatus for identifying genetic diseases and disorders; genome sequencing services in the nature of laboratory research; clinical research in the field of rapid whole genome sequencing test to enable the prevention, diagnosis and treatment of genetic diseases and disorders; development of technology that provides clinical guidance; platform as a service (PAAS) featuring computer software platform for data analysis, data management, data storage, data interpretation, and report generation, all in the field of genetics and genetic testing; clinical decision support technology in the nature of the provision of on-line non-downloadable software to assist in the translation of complex genomic sequencing for use in treatment plans by healthcare providers

medical diagnostic and treatment services, namely, whole genome sequencing testing for treating of genetic disease and disorders; providing medical screening for detecting genetic diseases in newborns; medical diagnosis, namely, translations of complex genomic sequencing for use in individualized patient treatment plans by healthcare providers for the diagnosis and treatment of genetically-linked diseases and conditions; providing genetic counseling and genetic information services